Clinical Trial Details


Research Study Summary

Myelodysplastic Syndrome (MDS)


To evaluate the efficacy of romiplostim for the treatment of thrombocytopenia in subjects with MDS

Patient Inclusion Criteria:

  • Diagnosis of MDS, 18+ years of age, adequate liver function, written informed consent

Patient Exclusion Criteria:

  • Have ever received any disease-modifying treatment MDS, Previously diagnosed with intermediate-2 or high risk MDS using the IPSS, prior history of leukemia, aplastic anemia, prior history of hematopoietic stem cell transplantation, active or uncontrolled infections, unstable angina, pregnant or breast feeding

To Learn more

CW ID: 163102
Date Last Changed: July 24, 2013

Clinical Trial Snapshot

Both Male and Female
18 and up
Overall Status
Facility Type


Dr. Tom Davis, Director of Business Development
Legacy Pharma Research
601 N. 5th St.
Bismarck, ND 58501
Phone: 701-751-1128
Fax: 701-751-1131

View Map

Volunteer for this Trial

If you would like to learn more about participating in this research study, please email the trial contact using the form below. We value your privacy and your information will only be used by the research center to contact you regarding this study.

DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.